CTOs on the Move

Procyrion

www.procyrion.com

 
Procyrion is developing the first catheter-deployed circulatory assist device intended for long-term use. The Procyrion device will be the first minimally invasive tool for cardiologists to treat over 1M NYHA Class III and early class IV heart failure (HF) patients in the US who have few therapeutic options. In partnership with Texas Heart Institute, Procyrion is currently conducting preclinical testing of the Procyrion device.
  • Number of Employees: 5K-10K
  • Annual Revenue: $0-1 Million
  • www.procyrion.com
  • 3900 Essex Lane Suite 250
    Houston, TX USA 77027
  • Phone: 334.663.4424

Executives

Name Title Contact Details

Funding

Procyrion raised $10M on 10/09/2015
Procyrion raised $30M on 07/11/2019

Similar Companies

Starkey

Starkey Hearing Technologies is a privately held, global hearing technology company headquartered in Eden Prairie, Minn. We are recognized for our innovative design, development and distribution of comprehensive digital hearing systems. We develop products using an evidence-based design approach, meaning that rigorous testing takes place to prove the benefits of a new technology or algorithm before a hearing aid is ever fit on a patient. Every Starkey Hearing Technologies employee is committed to helping people on their journey to better hearing every day. Starkey Hearing Technologies operates 21 facilities and conducts business in more than 100 markets worldwide. We develop, manufacture and distribute hearing aids via three distinct brands - Audibel, NuEar and our original brand, Starkey.

Seno Medical Instruments

Seno Medical Instruments, Inc. is a San Antonio, Texas-based medical imaging company committed to the development and commercialization of a new modality in cancer diagnosis: opto-acoustic imaging. Seno`s Imagio breast imaging system fuses opto-acoustic technology with ultrasound to generate functional and anatomical images of the breast. The opto-acoustic images provide a unique blood map in and around suspicious breast masses while the ultrasound provides a traditional anatomic image. Through the appearance or absence of the two hallmark indicators of cancer – angiogenesis and deoxygenation – Seno believes that the Imagio OA breast imaging system will be a more effective tool to help radiologists confirm or rule out malignancy than current diagnostic imaging modalities – without exposing patients to potentially harmful ionizing radiation (x-rays) or contrast agents.

MIGUN USA CORPORATION

MIGUN USA CORPORATION is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroLight Corporation of America

MicroLight Corporation of America is a Missouri City, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lifeline of Ohio

Lifeline of Ohio is a Columbus, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.